telitacicept
remegen
['telitacicept', 'remegen']
a leading #biopharmaceutical company, #remegen biosciences, will be attending (#acr) convergence 2022, hosted from november 10th to 14th. during the upcoming event, remegen will also present data from #telitacicept study for #sle. #acr2022 
We are a premier biotech media providing latest biotech news on research breakthroughs, in-depth biopharma insights, top KOL interviews, and global events.